✦ LIBER ✦

A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial

✍ Scribed by Saito, S.; Valdes-Chavarri, M.; Richardt, G.; Moreno, R.; Iniguez Romo, A.; Barbato, E.; Carrie, D.; Ando, K.; Merkely, B.; Kornowski, R.; Eltchaninoff, H.; James, S.; Wijns, W.

Book ID: 125848753
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 553 KB
Volume: 35
Category: Article
ISSN: 0195-668X
DOI: 10.1093/eurheartj/ehu210

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Prospective, Randomized Evaluation of

A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent: The PLATINUM (A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of up to Two De Novo Coronary Artery Lesions) Trial

✍ Gregg W. Stone; Paul S. Teirstein; Ian T. Meredith; Bruno Farah; Christophe L. D 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 825 KB

SIROLIMUS ELUTING STENT WITH BIODEGRADAB

SIROLIMUS ELUTING STENT WITH BIODEGRADABLE POLYMER VERSUS SIROLIMUS ELUTING STENT WITH DURABLE POLYMER FOR THE TREATMENT OF PATIENTS WITH DE NOVO CORONARY ARTERY LESIONS (EVOLUTION): A RANDOMIZED NON-INFERIORITY TRIAL

✍ Junbo Ge; Lei Ge; Juying Qian; Guosheng Fu; Huiliang Liu; Genshan Ma; Yitong Ma; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 106 KB

TCT-244: A Clinical Evaluation of the Pr

TCT-244: A Clinical Evaluation of the ProNOVA XR Polymer Free Sirolimus Eluting Coronary Stent System in the Treatment of Patients with De Novo Coronary Artery Lesions (EURONOVA Study)

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 83 KB

A clinical evaluation of the ProNOVA XR

A clinical evaluation of the ProNOVA XR polymer-free sirolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions (EURONOVA XR I study)

✍ Legutko, Jacek; Zasada, Wojciech; Kałuża, Grzegorz L.; Heba, Grzegorz; Rzeszutko 📂 Article 📅 2013 🏛 Cardiological Society of India 🌐 English ⚖ 589 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB

ISR II study: A long-term evaluation of

ISR II study: A long-term evaluation of sirolimus-eluting stent in the treatment of patients with in-stent restenotic native coronary artery lesions

✍ Philippe Commeau; Paul T. Barragan; Pierre O. Roquebert; Jean B. Siméoni 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

The aim of this pilot study was to determine the safety and long-term efficacy of treating intrastent restenosis (ISR) with the slow-release sirolimus-eluting stent Bx Velocity (Cypher stent) without intravascular ultrasound (IVUS) guidance. Of patients who received a bare metal stent implantation a